BostonGene

BostonGene

Verified
Biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer

Launch date
Employees
Ownership
Firm valuation
$600—900m (Dealroom.co estimates Apr 2022.)
Waltham Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound
N/A$50mSeries A
*
$150mSeries B
Total Funding$200m

Recent News about BostonGene

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.